Literature DB >> 12819047

Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen).

Robert R Brubaker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12819047      PMCID： PMC162007          DOI： 10.1128/IAI.71.7.3673-3681.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  107 in total

Review 1.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

2.  Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.

Authors:  Andreas Sing; Andreas Roggenkamp; Anna M Geiger; Jürgen Heesemann
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

3.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 4.  The Yersinia deadly kiss.

Authors:  G R Cornelis
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

5.  Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia.

Authors:  K L Guan; J E Dixon
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

Review 6.  Common themes in microbial pathogenicity revisited.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

7.  Plague bacillus: survival within host phagocytes.

Authors:  W A Janssen; M J Surgalla
Journal:  Science       Date:  1969-02-28       Impact factor: 47.728

8.  Cytoplasmic and membrane proteins of yersiniae cultivated under conditions simulating mammalian intracellular environment.

Authors:  S C Straley; R R Brubaker
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

9.  Proteolysis of V antigen from Yersinia pestis.

Authors:  R R Brubaker; A K Sample; D Z Yu; R J Zahorchak; P C Hu; J M Fowler
Journal:  Microb Pathog       Date:  1987-01       Impact factor: 3.738

10.  Consequences of aspartase deficiency in Yersinia pestis.

Authors:  L A Dreyfus; R R Brubaker
Journal:  J Bacteriol       Date:  1978-11       Impact factor: 3.490
View more
  88 in total

1.  Temporal global changes in gene expression during temperature transition in Yersinia pestis.

Authors:  Vladimir L Motin; Anca M Georgescu; Joseph P Fitch; Pauline P Gu; David O Nelson; Shalini L Mabery; Janine B Garnham; Bahrad A Sokhansanj; Linda L Ott; Matthew A Coleman; Jeffrey M Elliott; Laura M Kegelmeyer; Andrew J Wyrobek; Thomas R Slezak; Robert R Brubaker; Emilio Garcia
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

Review 2.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

3.  Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.

Authors:  Clarissa Cowan; Alexander V Philipovskiy; Christine R Wulff-Strobel; Zhan Ye; Susan C Straley
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.

Authors:  Alexander V Philipovskiy; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

5.  Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

Authors:  Kristin L DeBord; Deborah M Anderson; Melanie M Marketon; Katie A Overheim; R William DePaolo; Nancy A Ciletti; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

6.  Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Authors:  Ho-Ki Shim; Julie A Musson; Helen M Harper; Hesta V McNeill; Nicola Walker; Helen Flick-Smith; Alexei von Delwig; E Diane Williamson; John H Robinson
Journal:  Immunology       Date:  2006-08-18       Impact factor: 7.397

7.  Amino acid residues 196-225 of LcrV represent a plague protective epitope.

Authors:  Lauriane E Quenee; Bryan J Berube; Joshua Segal; Derek Elli; Nancy A Ciletti; Deborah Anderson; Olaf Schneewind
Journal:  Vaccine       Date:  2009-12-10       Impact factor: 3.641

8.  Substrains of 129 mice are resistant to Yersinia pestis KIM5: implications for interleukin-10-deficient mice.

Authors:  Joshua K Turner; John L Xu; Richard I Tapping
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

9.  Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Authors:  Wei Sun; Kenneth L Roland; Xiaoying Kuang; Christine G Branger; Roy Curtiss
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

10.  Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis.

Authors:  R William Depaolo; Fangming Tang; Inyoung Kim; Mei Han; Nadine Levin; Nancy Ciletti; Anning Lin; Debra Anderson; Olaf Schneewind; Bana Jabri
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.